Evidence map›Paper›PMID 31338160›Full record

ArticleAntimicrobial resistance and infection control2019

A cost-effectiveness analysis of mupirocin and chlorhexidine gluconate for

Elissa Rennert-May, John Conly, Stephanie Smith, Shannon Puloski, Elizabeth Henderson, Flora Au, Braden Manns

Abstract readComparative Study
In one paragraph

Article in Antimicrobial resistance and infection control, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Pre-surgical Nasal Decolonization ofOntario health technology assessment series · 2022
    Review
  3. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Elissa Rennert-May1Departments of Medicine and Community Health Sciences, University of Calgary, Calgary, Canada.ORCID 0000-0001-9884-6423
John Conly2Departments of Medicine; Microbiology, Immunology and Infectious Diseases; Pathology and Laboratory Medicine, O'Brien Institute for Public Health; Snyder Institute for Chronic Diseases, University of Calgary, Calgary, Canada.
Stephanie Smith3Department of Medicine, University of Alberta, Edmonton, Canada.
Shannon Puloski4Department of Surgery, University of Calgary, Calgary, Canada.
Elizabeth Henderson5Department of Community Health Sciences, University of Calgary, Calgary, Canada.
Flora Au6Department of Medicine, University of Calgary, Calgary, Canada.
Braden Manns7Departments of Medicine and Community Health Sciences, O'Brien Institute for Public Health and Libin Cardiovascular Institute, University of Calgary, HRIC Building, 2500 University Drive NW, Calgary, AB T2N1N4 Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: While decolonization of Methods: Decision analytic models and a probabilistic sensitivity analysis were used for a cost-effectiveness analysis, with the effectiveness of decolonization based on a large published pre- and post- intervention trial. The primary outcomes of the models were infections prevented and health care costs. We modelled the cost-effectiveness of decolonization in a hypothetical cohort of adult patients undergoing hip and knee replacement in Alberta, Canada. Information on the incidence of complex surgical site infections (SSIs), as well as the cost of care for patients with and without SSIs was taken from a provincial infection control database, and health administrative data. Results: Use of the decolonization bundle was cost saving compared to usual care ($153/person), and resulted in 16 complex Conclusions: Decolonization for

Indexed as

AdultAgedAlbertaArthroplasty, Replacement, HipArthroplasty, Replacement, KneeChlorhexidineCost-Benefit AnalysisDecision Support TechniquesFemaleHealth Care CostsHumansMaleMiddle AgedMupirocinPreoperative CareStandard of CareChlorhexidinechlorhexidine gluconateMupirocinCost-effectiveness analysisDecolonizationOrthopedic surgeriesSurgical site infections

Identifiers

PMID31338160
PMCPMC6625116

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.